| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |